Who owns Estomazil?
Estomazil is owned by Hypera (Brazil, B3: HYPE3).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Hypera Pharma — Corporate Profile (investor relations, updated 18 June 2026), 18 June 2026. Last checked .
Key facts
- Current owner
- Hypera Pharma reported
- Owner HQ
- 🇧🇷 Brazil, São Paulo
- Origin
- 🇧🇷 Brazil
- Category
- Consumer health › Over-the-counter medicine › Digestive health
- Parent ticker
- B3: HYPE3
- Last verified
- · 1 sources
About Estomazil
Estomazil is Hypera Pharma's antacid brand for heartburn and indigestion. It is sold as an effervescent sodium bicarbonate powder in 5-gram sachets flavoured with pineapple, orange or guaraná or unflavoured, as chewable tablets, and as Leite de Magnésia Estomazil, a milk of magnesia that also works as a mild laxative.
Ownership timeline of Estomazil
Where Estomazil sits in Hypera
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Hypera ownership tree →
See the full Hypera brand portfolio (8) →
Other brands owned by Hypera
Hypera controls 8 brands on Brandtree, 5 of them in consumer health.
Also in consumer health
Other brands in digestive health, and who owns them
The 25 brands in digestive health on Brandtree belong to 18 owners. The largest is Bayer, with 2; Hypera has 2.
| Brand | Owner | Owner based in |
|---|---|---|
| Alka-Seltzer | Bayer | 🇩🇪 Germany |
| Daiichi Sankyo Stomach Medicine | Daiichi Sankyo Healthcare | 🇯🇵 Japan |
| Kaopectate | Genomma Lab | 🇲🇽 Mexico |
| Entrostop | Kalbe Farma | 🇮🇩 Indonesia |
| Metamucil | Procter & Gamble | 🇺🇸 United States |
| Buscolysin | Sopharma | 🇧🇬 Bulgaria |
| Oracal | Birzeit Pharmaceutical | 🇵🇸 Palestine |
| First Response | Church & Dwight | 🇺🇸 United States |
About the owner: Hypera
Hypera is a publicly listed company headquartered in São Paulo, Brazil, founded in 2001. Brandtree records 8 brands under its control, and it is listed as B3: HYPE3.
Hypera Pharma is a Brazilian pharmaceutical company that began operating in December 2001 as a consumer goods business and moved into medicines in 2007, selling its cosmetics and disposables operations in 2015 and 2017. It leads the Brazilian over-the-counter medicines market and has been listed on B3's Novo Mercado since 2008. Votorantim S.A. joined its controlling shareholder group in 2025.
🇧🇷 Estomazil and other Brazilian brands
Brandtree records a controlling owner for 177 brands that began in Brazil. 32 of them (18%) are now controlled by a company headquartered in another country; Estomazil is not one of them.
- Adria — M. Dias Branco 🇧🇷
- Aena Brasil — Aena 🇪🇸
- Alexandre Birman — Azzas 2154 🇧🇷
- Arteris — Mundys 🇮🇹
- Ashua Curve & Plus Size — Lojas Renner 🇧🇷
- Assaí Atacadista — Assaí 🇧🇷
Frequently asked questions
Who is the parent company of Estomazil?
The parent company of Estomazil is Hypera, a publicly listed company headquartered in Brazil.
Is Estomazil Brazilian?
Yes. Estomazil originated in Brazil and its owner, Hypera, is also headquartered in Brazil.
Is Estomazil still owned by Hypera?
Yes. As of 16 September 2026, Estomazil is still owned by Hypera. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Hypera Pharma — Corporate Profile (investor relations, updated 18 June 2026) — Hypera Pharma, Official document, published 18 June 2026; retrieved 16 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.